Evidence map›Paper›PMID 40553309›Full record

ArticleInternational urology and nephrology2026

One-night catheter stay after Holmium laser enucleation of the prostate: a single-center comparative study.

Alessandro Veccia, Alberto Bianchi, Francesca Fumanelli, Claudio Brancelli, Francesco Ditonno, Francesca Montanaro, Greta Pettenuzzo, Sarah Malandra, Riccardo Rizzetto, Emanuele Rubilotta and 3 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alessandro Veccia *Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Alberto Bianchi *Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Francesca FumanelliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Claudio BrancelliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Francesco DitonnoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Francesca MontanaroDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Greta PettenuzzoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Sarah MalandraResidency Program in Health Statistics and Biometrics, University of Verona, Verona, Italy.
Riccardo RizzettoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Emanuele RubilottaDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Maria Angela CerrutoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Riccardo BertoloDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy. riccardogiuseppe.bertolo@univr.it.
Alessandro AntonelliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHolmium laser enucleation of the prostate (HoLEP) is an effective treatment for benign prostatic hyperplasia (BPH). This study aimed to assess the impact of catheterization duration on postoperative outcomes, focusing on re-catheterization rates and associated risk factors.

methodsA retrospective analysis was conducted on patients who underwent HoLEP at our institution (June 2022-August 2024). Starting in November 2023, we decided to attempt catheter removal the morning after the procedure unless contraindicated. Patients were categorized into two groups based on catheterization duration: > 1 day (Group A) and ≤ 1 day (Group B). Perioperative variables, functional outcomes, and re-catheterization rates were compared between the groups. Multivariable logistic regression models were used to identify independent predictors of re-catheterization.

results258 patients were analyzed. Baseline characteristics, including age, BMI, IPSS, Q

conclusionEarly catheter removal after HoLEP is safe and effective, reducing re-catheterization risk without compromising outcomes. Early removal may also enhance postoperative recovery by minimizing infections.

Indexed as

Lasers, Solid-StateLaser TherapyLength of StayProstatectomyProstatic HyperplasiaUrinary CatheterizationAgedHumansMaleMiddle AgedRetrospective StudiesTime FactorsBenign prostatic hyperplasiaCatheterizationEnucleationHoLEPRe-catheterization

Identifiers

PMID40553309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.